RhumbLine Advisers’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$395K Sell
1,725
-14
-0.8% -$3.14K ﹤0.01% 2751
2025
Q4
$371K Buy
1,739
+604
+53% +$125K ﹤0.01% 2847
2025
Q3
$226K Sell
1,135
-306
-21% -$57.1K ﹤0.01% 3164
2025
Q2
$249K Buy
1,441
+55
+4% +$8.96K ﹤0.01% 3107
2025
Q1
$216K Sell
1,386
-74
-5% -$10.6K ﹤0.01% 3069
2024
Q4
$201K Sell
1,460
-108
-7% -$14.2K ﹤0.01% 3198
2024
Q3
$234K Buy
1,568
+35
+2% +$4.73K ﹤0.01% 3157
2024
Q2
$209K Buy
1,533
+143
+10% +$19.5K ﹤0.01% 3202
2024
Q1
$210K Buy
1,390
+100
+8% +$14.3K ﹤0.01% 3151
2023
Q4
$162K Buy
1,290
+22
+2% +$2.19K ﹤0.01% 3281
2023
Q3
$119K Buy
1,268
+10
+0.8% +$936 ﹤0.01% 3401
2023
Q2
$112K Buy
+1,258
New +$109K ﹤0.01% 3479

Other funds holding ASND